Abstract:

Acute Respiratory Distress Syndrome (ARDS) remains one of the most formidable challenges in modern critical care, characterized by diffuse alveolar damage, severe hypoxemia, and significant mortality despite advances in supportive care. Traditional ventilation strategies have focused on lung-protective principles, particularly the use of low tidal volumes (6 mL/kg predicted body weight) and limitation of plateau pressures to reduce ventilator-induced lung injury (VILI). While these approaches have significantly improved outcomes, ARDS is increasingly recognized as a heterogeneous syndrome with variable pathophysiological phenotypes, necessitating a more individualized approach to mechanical ventilation.

This presentation explores the emerging concept of precision ventilation, which integrates patient-specific respiratory mechanics, imaging, and biological markers to tailor ventilatory support. Central to this approach is the optimization of driving pressure, now understood to be a key determinant of survival. By minimizing the difference between plateau pressure and positive end-expiratory pressure (PEEP), clinicians can better prevent overdistension and cyclic atelectasis. The session will also address methods of PEEP titration, comparing traditional tables with advanced techniques such as decremental PEEP trials and compliance-guided strategies.

Recent technological advancements, including electrical impedance tomography (EIT), provide real-time bedside imaging of regional lung ventilation, enabling clinicians to identify recruitable lung areas and avoid hyperinflation. Similarly, esophageal manometry offers insight into transpulmonary pressures, facilitating more accurate adjustments in patients with altered chest wall mechanics, such as obesity or abdominal hypertension. These tools are instrumental in transitioning from generalized to precision-based care.

Adjunctive therapies remain a cornerstone in the management of moderate-to-severe ARDS. Prone positioning has demonstrated mortality benefits by improving ventilation-perfusion matching and reducing dorsal lung compression. Neuromuscular blockade, when used early and judiciously, may improve ventilator synchrony and oxygenation. Furthermore, extracorporeal membrane oxygenation (ECMO) has emerged as a life-saving intervention for refractory hypoxemia, with expanding indications supported by recent clinical trials.

The integration of artificial intelligence and machine learning into ventilatory management is an exciting frontier. Predictive models based on large datasets may soon assist clinicians in identifying optimal ventilator settings and forecasting disease progression. However, challenges remain in translating these innovations into routine practice, including cost, training, and standardization of protocols.

In conclusion, precision ventilation represents a paradigm shift in the management of ARDS, moving beyond standardized protocols toward individualized care strategies that account for patient-specific physiology. By combining advanced monitoring technologies, evidence-based adjunctive therapies, and emerging digital tools, clinicians can enhance outcomes and reduce the burden of this complex syndrome. This session aims to equip attendees with both the theoretical framework and practical tools necessary to implement precision ventilation in diverse critical care settings.